Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Student electives for Gina Hadley, Clare Webb, Zoeb Jiwaji, Emily Parker and Jonarthan Thevanayagam. (360G-Wellcome-083630_Z_07_Z)

Malaria is one of the deadliest infectious parasitic diseases. Combination therapy, which has already been introduced in Kenya may not address the problem of the ability of the parasite to quickly select for resistance against antimalarial drugs, due to the detrimental effect of disparate pharmacokinetic profiles of drugs used. Strategies have to be devised to tackle the drug resistance. One such strategy is to predict and monitor the emergence and the spread of drug resistance parasite before drug resistance become s a problem. As Co-artem® has already been introduced in Kenya, the information that this project will provide is vital.


18 Jul 2007

Grant details
Amount Awarded 5600
Applicant Surname Lancaster
Approval Committee Neurosciences And Mental Health
Award Date 2007-07-18T00:00:00+00:00
Financial Year 2006/07
Grant Programme: Title Studentship: Inactive scheme
Internal ID 083630/Z/07/Z
Lead Applicant Dr Tim Lancaster
Planned Dates: End Date 2008-08-10T00:00:00+00:00
Planned Dates: Start Date 2007-07-11T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East
Additional data added by GrantNav